pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

8,216 catalysts · 5,539 phase readout · 2,295 8k filing · 379 pdufa · 241 earnings · 2 approval · 1 adcom

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-08-03: 0 catalysts2026-08-04: 47 catalysts2026-08-05: 18 catalysts2026-08-06: 12 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 2 catalysts2026-08-11: 1 catalyst2026-08-12: 2 catalysts2026-08-13: 2 catalysts2026-08-14: 1 catalyst2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 1 catalyst2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 1 catalyst2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 1 catalyst2026-10-14: 0 catalysts2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 0 catalysts2026-10-20: 1 catalyst2026-10-21: 1 catalyst2026-10-22: 2 catalysts2026-10-23: 0 catalysts2026-10-24: 0 catalysts2026-10-25: 0 catalysts2026-10-26: 0 catalysts2026-10-27: 2 catalysts2026-10-28: 1 catalyst2026-10-29: 3 catalysts2026-10-30: 1 catalyst2026-10-31: 0 catalysts2026-11-01: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type
  • phase readout5,539
  • 8k filing2,295
  • pdufa379
  • earnings241
  • approval2
  • adcom1
therapy area

no tagged catalysts yet

Date TBD

50
›COMPLETEDphase readoutNCT07200401: Exploring if Patients Can Safely and Easily Swab Their Own Surgical Wounds at Home

Sponsor: Guy's and St Thomas' NHS Foundation Trust. Phase: NA. Conditions: Cardiac Surgery, Infection, Soft Tissue, Wound Healing, Swabs, Self Management

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07506681: IMAT Quality in Aging

Sponsor: Washington University School of Medicine. Phase: NA. Conditions: Aging

full page →ctgov ↗
›RECRUITINGphase readoutNCT06184581: Lithium Versus Lamotrigine in Bipolar Disorder, Type II

Sponsor: University Hospital Bispebjerg and Frederiksberg. Phase: PHASE4. Conditions: Bipolar II Disorder

full page →ctgov ↗
›RECRUITINGphase readoutNCT04642430: COmparison of Bleeding Risk Between Rivaroxaban and Apixaban in Patients With Atrial Fibrillation

Sponsor: Ottawa Hospital Research Institute. Phase: PHASE4. Conditions: Atrial Fibrillation

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07408830: VA Randomized Trial of Surveillance Intervals After Transurethral Resection of High Grade Bladder Tumors

Sponsor: VA Office of Research and Development. Phase: NA. Conditions: High-Grade Early-Stage Bladder Cancer

full page →ctgov ↗
›COMPLETEDphase readoutNCT07603830: Personality Type, Leadership Style and Training Needs Among Nurses

Sponsor: Sri Ramachandra Institute of Higher Education and Research. Phase: . Conditions: Personality Type, Leadership Style, Training Status

full page →ctgov ↗
›COMPLETEDphase readoutNCT06479330: Evaluating the Impact of Incremental Doses of a Sugar Replacer Blend on Gastrointestinal Tolerance in Chocolate

Sponsor: Mondelēz International, Inc.. Phase: NA. Conditions: Gastrointestinal Tolerance, Healthy Population

full page →ctgov ↗
›RECRUITINGphase readoutNCT03991728: Alloplastic Total Temporomandibular Joint (TMJ) Replacement Registry

Sponsor: AO Innovation Translation Center. Phase: . Conditions: Temporomandibular Joint Disorders

full page →ctgov ↗
›RECRUITINGphase readoutNCT05691465: Testing the Safety and Effectiveness of Radiation-based Treatment (Lutetium Lu 177 Dotatate) for Metastatic Prostate Cancer That Has Neuroendocrine Cells

Sponsor: National Cancer Institute (NCI). Phase: PHASE2. Conditions: Metastatic Prostate Adenocarcinoma With Neuroendocrine Differentiation, Metastatic Prostate Neuroendocrine Carcinoma, Metastatic Prostate Small Cell Neuroendocrine Carcinoma, Stage IVB Prostate Cancer AJCC v8

full page →ctgov ↗
›RECRUITINGphase readoutNCT07119567: Impact of Cocaine Use and Withdrawal on Sleep

Sponsor: Hôpital le Vinatier. Phase: . Conditions: Cocaine Use Disorder

full page →ctgov ↗
›NO_LONGER_AVAILABLEphase readoutNCT05779267: NRX-101 Expanded Access

Sponsor: NeuroRx, Inc.. Phase: . Conditions: Bipolar Depression, Bipolar Affective Disorder

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT07621900: Effects of Lokomat Training on Dynamic Postural Stability in Incomplete Spinal Cord Injury

Sponsor: I.R.C.C.S. Fondazione Santa Lucia. Phase: NA. Conditions: Spinal Cord Injury

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07495800: Weight and BMI Patterns in Biological Based IBD Patients and Its Finacial Impact

Sponsor: Assiut University. Phase: . Conditions: Inflammatory Bowel Diseases Weight Changes

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT04911400: Effects of Class III Elastics on Stability of Orthopaedic Class III Correction

Sponsor: Sydney Local Health District. Phase: NA. Conditions: Class III Malocclusion, Underbite

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07547592: Gemcitabine and Docetaxel With or Without Bevacizumab (Onbevzi) for Soft Tissue Sarcoma

Sponsor: Yonsei University. Phase: PHASE2. Conditions: Neoplasms of Connective and Soft Tissue With an Unspecified Anatomical Site

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT05779592: A Study to Evaluate Nivolumab in Japanese Participants With Muscle-invasive Urothelial Carcinoma

Sponsor: Bristol-Myers Squibb. Phase: . Conditions: Muscle-invasive Urothelial Carcinoma

full page →ctgov ↗
›RECRUITINGphase readoutNCT07341711: Long-term Adaptations of Skeletal Muscle After Hybrid Training

Sponsor: University of Thessaly. Phase: NA. Conditions: Obesity & Overweight

full page →ctgov ↗
›RECRUITINGphase readoutNCT07289711: Validation and Precision Treatment of Inflammatory Subphenotypes in Acute Respiratory Distress Syndrome: A Multicenter Cohort Study

Sponsor: Southeast University, China. Phase: . Conditions: Acute Respiratory Distress Syndrome

full page →ctgov ↗
›RECRUITINGphase readoutNCT07542171: Clinical Outcomes After Non-curative Endoscopic Resection in Early Colorectal Cancer: A Multicenter Study

Sponsor: Nanfang Hospital, Southern Medical University. Phase: . Conditions: Early Colorectal Cancer, Non-curative Endoscopic Resection

full page →ctgov ↗
›RECRUITINGphase readoutNCT00091871: A Longitudinal Study of Familial Hypereosinophilia (FE): Natural History and Markers of Disease Progression

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID). Phase: . Conditions: Eosinophilia, Hypereosinophilic Syndrome

full page →ctgov ↗
›COMPLETEDphase readoutNCT06498427: Adolescents' Well-being in Community-based Treatment Versus Residential Treatment

Sponsor: Outcome Referrals, Inc.. Phase: . Conditions: Adolescent Well-Being, Mental Disorders, Severe

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07590427: Periosteal Muscular Flap in Reconstruction of Small and Medium Sized Defects at Floor of the Mouth

Sponsor: Alexandria University. Phase: NA. Conditions: Maxillofacial Reconstruction

full page →ctgov ↗
›COMPLETEDphase readoutNCT05991661: XKH001 Injection in Healthy Subjects

Sponsor: Beijing Kanova Biopharmaceutical Co., LTD. Phase: PHASE1. Conditions: Asthma

full page →ctgov ↗
›RECRUITINGphase readoutNCT06804642: Spinal Cord Stimulation for Parkinson's Disease Rehabilitation

Sponsor: University of Louisville. Phase: NA. Conditions: Parkinson Disease

full page →ctgov ↗
›COMPLETEDphase readoutNCT06563570: The Effect of Teleyoga in Liver Transplant Patients

Sponsor: Dokuz Eylul University. Phase: NA. Conditions: Liver Transplant Disorder

full page →ctgov ↗
›RECRUITINGphase readoutNCT01276470: Environmental Risk Factors for the Anti-synthetase Syndrome

Sponsor: National Institute of Environmental Health Sciences (NIEHS). Phase: . Conditions: Myositis, Dermatomyositis, Polymyositis, Juvenile Dermatomyositis, Juvenile Polymyositis

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07619183: A Study to Evaluate the Multiple Dose Ascending of PG-033 in Healthy Adult Participants.

Sponsor: Prime Gene Therapeutics Co., Ltd.. Phase: PHASE1. Conditions: Lichen Simplex Chronicus

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT06189183: Adjuvant Hypofractionation Radiotherapy for Thymic Epithelial Tumours After Complete Resection

Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences. Phase: NA. Conditions: Thymus Neoplasms

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT06854094: Consolidation Therapy With Cladribine in Relapsing Multiple Sclerosis Patients

Sponsor: Ente Ospedaliero Cantonale, Bellinzona. Phase: . Conditions: Multiple Sclerosis

full page →ctgov ↗
›COMPLETEDphase readoutNCT06857994: The Association Between Cognitive Function and Neuropathy in Individuals With Type 2 Diabetes

Sponsor: Steno Diabetes Center Copenhagen. Phase: . Conditions: Peripheral Diabetic Neuropathy, Cardiovascular Autonomic Neuropathy, Cognitive Impairment, Diabetes Type 2

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT04634266: TRICuspid Intervention in Heart Failure Trial

Sponsor: LMU Klinikum. Phase: NA. Conditions: Heart Failure Attributable to Severe Tricuspid Regurgitation

full page →ctgov ↗
›COMPLETEDphase readoutNCT03038022: Study of MGL-3196 in Patients With Heterozygous Familial Hypercholesterolemia (HeFH)

Sponsor: Madrigal Pharmaceuticals, Inc.. Phase: PHASE2. Conditions: Heterozygous Familial Hypercholesterolemia

full page →ctgov ↗
›COMPLETEDphase readoutNCT06931522: Effects of Mat and Reformer Pilates in Multiple Sclerosis

Sponsor: Gazi University. Phase: NA. Conditions: Multiple Sclerosis

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07619222: Correlation and Prognostic Value of Body Composition, Cardiac Structure and Function in Patients With Different Heart Failure Subtypes

Sponsor: Beijing Anzhen Hospital. Phase: . Conditions: Heart Failure

full page →ctgov ↗
›ENROLLING_BY_INVITATIONphase readoutNCT07373951: Retrospective Multicenter Study of Patient-level T1CE/FLAIR MRI Deep Learning to Predict EGFR/ALK Driver Status in NSCLC Brain Metastases With External Validation and Survival Analysis

Sponsor: Ming Yang. Phase: . Conditions: Non-Small Cell Lung Cancer, Brain Metastases

full page →ctgov ↗
›RECRUITINGphase readoutNCT06270251: Modeling Tic Change During Behavior Therapy for Tics

Sponsor: University of Minnesota. Phase: NA. Conditions: Chronic Tic Disorder

full page →ctgov ↗
›COMPLETEDphase readoutNCT06289829: The Appropriate Remifentanil Dose for Optimal Insertion of Laryngeal Mask Airway in Adult Patients During Induction of General Anesthesia Using Remimazolam.

Sponsor: Yonsei University. Phase: NA. Conditions: Adult, Laryngeal Masks, Remimazolam, Remifentanil

full page →ctgov ↗
›COMPLETEDphase readoutNCT07376031: Cervical Thermal Ablation to Treat Persistent HPV Infection

Sponsor: Hvidovre University Hospital. Phase: NA. Conditions: Cervical Cancer Screening, HPV, Thermal Ablation

full page →ctgov ↗
›COMPLETEDphase readoutNCT07656402: Role Model-Based Ethics Education and Moral Injury Prevention in Second-Year Medical Students

Sponsor: Chun Lun Hsu. Phase: NA. Conditions: Moral Injury, Perceived Stress, Resilience, Ethics Education

full page →ctgov ↗
›RECRUITINGphase readoutNCT06736002: Effects of Mega-dose Vitamin D Pulse and Maintenance Therapy on Seizure Frequency, Fatigue, and Quality of Life: A Prospective Study

Sponsor: Chin-Wei Huang. Phase: NA. Conditions: Epilepsy

full page →ctgov ↗
›COMPLETEDphase readoutNCT07481045: Compensatory Inferior Turbinate Surgery in Septorhinoplasty

Sponsor: Saglik Bilimleri Universitesi. Phase: NA. Conditions: Nasal Obstruction Septal Deviation Compensatory Inferior Turbinate Hypertrophy

full page →ctgov ↗
›TERMINATEDphase readoutNCT04222972: A Study of Pralsetinib Versus Standard of Care for First-Line Treatment of Advanced Non-Small Cell Lung Cancer (NSCLC)

Sponsor: Hoffmann-La Roche. Phase: PHASE3. Conditions: RET-fusion Non Small Cell Lung Cancer, Lung Neoplasm, Carcinoma, Non-Small-Cell Lung, Respiratory Tract Neoplasms, Thoracic Neoplasms, Neoplasms by Site, Neoplasms, Lung Diseases, Respiratory Tract Disease, Carcinoma, Bronchogenic, Bronchial Diseases, Head and Neck Neoplasms, Adenocarcinoma, Carcinoma, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue

full page →ctgov ↗
›RECRUITINGphase readoutNCT07362095: Luspatercept for the Treatment of Anemia Following Allogeneic Hematopoietic Stem Cell Transplantation(Allo-HSCT)

Sponsor: Zhujiang Hospital. Phase: PHASE1. Conditions: Acute Leukemia

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT07167277: The Impact of Whey Protein on Frailty in Older Adults Classified as Pre-frail

Sponsor: University of Kansas Medical Center. Phase: NA. Conditions: Pre-frail, Pre-Frail Older Adults, Cognition, Physical Function, Dietary Intake Assessment, MRI

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07593677: Motivating Activity Through Text Communications - Helping Adults Increase Movement

Sponsor: University of Michigan. Phase: NA. Conditions: Physical Inactivity, Aging, Cognitive Ability, Behavior Change

full page →ctgov ↗
›COMPLETEDphase readoutNCT03604757: 68Ga-RM2 Compared to 68Ga-PSMA-617 PET/CT for Prostate Cancer Imaging According to Various Metastatic Risks

Sponsor: University Hospital, Bordeaux. Phase: PHASE2. Conditions: Prostate Cancer

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07350057: A Preliminary Clinical Study on the Efficacy of Cyclophosphamide and Sirolimus Combined With VIC-1911 in Preventing Graft-versus-Host Disease After Haploidentical Stem Cell Transplantation in Children

Sponsor: Shanghai Jiao Tong University School of Medicine. Phase: PHASE1. Conditions: GVHD (Acute or Chronic)

full page →ctgov ↗
›COMPLETEDphase readoutNCT07386301: Open Membrane Technique as an Innovative Minimally Invasive Technique for Bone Augmentation

Sponsor: Saint-Joseph University. Phase: NA. Conditions: Bone Graft, Keratinized Tissue

full page →ctgov ↗
›RECRUITINGphase readoutNCT07260812: KSV01 Injection for the Treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma

Sponsor: TCRx Therapeutics Co.Ltd. Phase: PHASE1. Conditions: Non-Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma (DLBCL)

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT00119912: NORCCAP: Norwegian Colorectal Cancer Prevention Trial

Sponsor: Norwegian Institute of Public Health. Phase: NA. Conditions: Colorectal Cancer, Adenoma

full page →ctgov ↗
← prev
page 123 of 165
next →